A Clinical Trial That Will Study the Efficacy and Safety of an Investigational Drug in Acutely Psychotic People With Schizophrenia
Clinical trial NCT04092686 · COMPLETED
Trial details
- NCT number
- NCT04092686
- Sponsor
- Otsuka Pharmaceutical Development & Commercialization, Inc.
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2019-10-14
- Primary completion
- 2023-06-14
- Enrollment
- 464
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.